ECSP13012535A - HETEROCYCLIC COMPOUND AND ITS USES - Google Patents

HETEROCYCLIC COMPOUND AND ITS USES

Info

Publication number
ECSP13012535A
ECSP13012535A ECSP13012535A ECSP13012535A EC SP13012535 A ECSP13012535 A EC SP13012535A EC SP13012535 A ECSP13012535 A EC SP13012535A EC SP13012535 A ECSP13012535 A EC SP13012535A
Authority
EC
Ecuador
Prior art keywords
heterocyclic compound
activity
secretase
superior
symbol
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Tatsuki Koike
Takafumi Takai
Yasutaka Hoashi
Tetsuya Tsukamoto
Makoto Kamata
Minoru Nakamura
Yoshihide Tomata
Yuichi Kajita
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45094181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13012535(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ECSP13012535A publication Critical patent/ECSP13012535A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención proporciona un derivado heterociclo que tiene una actividad inhibidora de la producción de amiloide superior y/o una actividad de modulación de -secretasa superior, y el uso del mismo. Un compuesto representado por la fórmula (I):donde cada símbolo es como se define en la presente memoria descriptiva, o una sal del mismo.The present invention provides a heterocycle derivative that has an inhibitory activity of the production of higher amyloid and / or a modulation activity of -secretase superior, and the use thereof. A compound represented by the formula (I): where each symbol is as defined herein, or a salt thereof.

ECSP13012535 2010-09-02 2013-03-28 HETEROCYCLIC COMPOUND AND ITS USES ECSP13012535A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010197064 2010-09-02
JP2011143548 2011-06-28

Publications (1)

Publication Number Publication Date
ECSP13012535A true ECSP13012535A (en) 2013-06-28

Family

ID=45094181

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012535 ECSP13012535A (en) 2010-09-02 2013-03-28 HETEROCYCLIC COMPOUND AND ITS USES

Country Status (22)

Country Link
US (3) US8822699B2 (en)
EP (1) EP2611805A1 (en)
JP (1) JP5871909B2 (en)
KR (1) KR20130139895A (en)
CN (1) CN103249733A (en)
AR (1) AR082865A1 (en)
AU (1) AU2011296887A1 (en)
BR (1) BR112013004746A2 (en)
CA (1) CA2809779A1 (en)
CL (1) CL2013000575A1 (en)
DO (1) DOP2013000051A (en)
EA (1) EA201390333A1 (en)
EC (1) ECSP13012535A (en)
MA (1) MA34556B1 (en)
MX (1) MX2013002511A (en)
PE (1) PE20131305A1 (en)
PH (1) PH12013500403A1 (en)
SG (1) SG187917A1 (en)
TW (1) TW201213327A (en)
UY (1) UY33586A (en)
WO (1) WO2012029991A1 (en)
ZA (1) ZA201301929B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120142672A1 (en) * 2009-07-13 2012-06-07 Tatsuki Koike Heterocyclic compound and use thereof
UY33586A (en) * 2010-09-02 2012-03-30 Takeda Pharmaceutical HETEROCYCLIC COMPOUND AND ITS USES
EP2687528A1 (en) * 2012-07-17 2014-01-22 Ares Trading S.A. Fused triazole derivatives as gamma secretase modulators
RU2563254C2 (en) * 2013-07-08 2015-09-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Method of obtaining derivatives of 7-(hetero)aryl-4,5,6,7-tetrahydro[1,2,3]triazolo[1,5-a]pyridine
RU2750293C2 (en) * 2015-05-12 2021-06-25 ЭфЭмСи Корпорейшн Aryl-substituted bicyclic compounds as herbicides
MY202326A (en) * 2017-09-14 2024-04-24 Daiichi Sankyo Co Ltd Compound having cyclic structure
US20210079182A1 (en) * 2019-09-12 2021-03-18 Dupont Electronics, Inc. Polyimide films and electronic devices
IL313039A (en) * 2021-12-17 2024-07-01 Athira Pharma Inc Uses of bicyclic compounds for the treatment of diseases
CN118047687A (en) * 2024-01-29 2024-05-17 湖州澄博生物科技有限公司 A compound for modifying the structure of 20(S) camptothecin and its synthesis method

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1261610A2 (en) 2000-02-17 2002-12-04 Bristol-Myers Squibb Pharma Company Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
CN102584813B (en) 2003-05-14 2016-07-06 Ngc药物公司 Compound and the purposes in regulating amyloid beta thereof
CA2539811A1 (en) * 2003-10-15 2005-04-28 Targacept, Inc. Azabicycyclic compounds for relieving pain and treating central nervous system disorders
EP2261218B1 (en) 2004-05-26 2013-04-03 Eisai R&D Management Co., Ltd. Imidazole compound for use as an intermediate in the production of cinnamide compounds
KR20070083781A (en) 2004-10-26 2007-08-24 에자이 알앤드디 매니지먼트 가부시키가이샤 Amorphous of Cinnamid Compound
JP2009523170A (en) 2006-01-11 2009-06-18 メルク エンド カムパニー インコーポレーテッド Condensed triazole tachykinin receptor andanist
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
GEP20115139B (en) 2006-03-09 2011-01-10 Eisai R&D Man Co Ltd Polycyclic cinnamide derivative
TW200808800A (en) 2006-05-05 2008-02-16 Astrazeneca Ab MGluR5 modulators V
TW200835502A (en) 2006-12-26 2008-09-01 Daiichi Sankyo Co Ltd Thiazepine derivatives
US8143394B2 (en) 2006-12-26 2012-03-27 Gilead Sciences, Inc. Pyrido(3,2-d)pyrimidines useful for treating viral infections
WO2008097538A1 (en) 2007-02-08 2008-08-14 Merck & Co., Inc. Therapeutic agents
MX2010006243A (en) 2007-12-06 2010-08-31 Schering Corp Gamma secretase modulators.
TW201030002A (en) * 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2010197064A (en) 2009-02-23 2010-09-09 Chugoku Electric Power Co Inc:The Device for measuring position just below
JP2012051806A (en) * 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd Imidazolylpyrazine derivative
RU2515976C2 (en) 2009-02-26 2014-05-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Condensed heterocyclic nitrogen compounds and using them as inhibitors of amyloid beta production
JP2012051807A (en) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd Arylimidazole compound
WO2011002067A1 (en) 2009-07-02 2011-01-06 武田薬品工業株式会社 Heterocyclic compound and use thereof
US20120142672A1 (en) * 2009-07-13 2012-06-07 Tatsuki Koike Heterocyclic compound and use thereof
WO2011006903A1 (en) 2009-07-15 2011-01-20 Ortho-Mcneil-Janssen Pharmaceuticals, Inc Substituted triazole and imidazole derivatives as gamma secretase modulators
US8637525B2 (en) 2009-07-31 2014-01-28 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
TWI468402B (en) 2009-07-31 2015-01-11 必治妥美雅史谷比公司 Compounds for the reduction of β-amyloid production
WO2011016559A1 (en) 2009-08-07 2011-02-10 武田薬品工業株式会社 Heterocyclic compound and use thereof
JP2011143548A (en) 2010-01-12 2011-07-28 Panasonic Corp Screen printing machine and screen printing method
PH12012501381A1 (en) 2010-01-15 2012-10-22 Janssen Pharmaceuticals Inc Novel substituted bicyclic triazole derivatives as gamma secretase modulators
UY33586A (en) * 2010-09-02 2012-03-30 Takeda Pharmaceutical HETEROCYCLIC COMPOUND AND ITS USES

Also Published As

Publication number Publication date
CN103249733A (en) 2013-08-14
MX2013002511A (en) 2013-07-29
PE20131305A1 (en) 2013-10-31
WO2012029991A1 (en) 2012-03-08
SG187917A1 (en) 2013-04-30
CA2809779A1 (en) 2012-03-08
UY33586A (en) 2012-03-30
CL2013000575A1 (en) 2013-08-23
EP2611805A1 (en) 2013-07-10
EA201390333A1 (en) 2013-08-30
US20130178497A1 (en) 2013-07-11
AU2011296887A1 (en) 2013-04-11
AR082865A1 (en) 2013-01-16
US8822699B2 (en) 2014-09-02
US20120059030A1 (en) 2012-03-08
JP5871909B2 (en) 2016-03-01
DOP2013000051A (en) 2013-04-30
TW201213327A (en) 2012-04-01
PH12013500403A1 (en) 2013-03-25
JP2013536798A (en) 2013-09-26
MA34556B1 (en) 2013-09-02
US20140350260A1 (en) 2014-11-27
KR20130139895A (en) 2013-12-23
BR112013004746A2 (en) 2016-06-07
US8901309B2 (en) 2014-12-02
ZA201301929B (en) 2013-11-27

Similar Documents

Publication Publication Date Title
UY33586A (en) HETEROCYCLIC COMPOUND AND ITS USES
UY36199A (en) HETEROCYCLIC COMPOUND
CR20150509A (en) USEFUL NAFTIRIDINE DERIVATIVES AS ANTAGONISTS OF THE ALFA-V-BETA-6 INTEGRINE
MX368392B (en) FUSED HETEROCYCLIC COMPOUND.
UY36489A (en) USE OF PICOLINAMIDE COMPOUNDS WITH FUINGICIDE ACTIVITY
CU24408B1 (en) DIHYDROISOQUINOLINONA SUBSTITUTED COMPOUNDS
MX2016003199A (en) AZAPIRIDONE COMPOUNDS AND USES OF THE SAME.
UY33943A (en) SCIROCYCLIC DERIVATIVES OF ISOXAZOLINE AS ANTIPARASITARY AGENTS.
CO2017001178A2 (en) Derivative of pyridone having a tetrahydropyranyl methyl group
BR112016014020A8 (en) tetrahydropyridopyrazines modulators of gpr6.
MX372736B (en) AZAQUINAZOLINE INHIBITORS OF ATYPICAL PROTEIN KINASE C.
MX2013006113A (en) Bicyclic compound.
BR112017013062A2 (en) macrocyclic picolinamide compounds with fungicidal activity.
BR112016006076A2 (en) macrocyclic picolinamide compounds with fungicidal activity
CO2019012125A2 (en) Ip6k inhibitors
MX2017002312A (en) Heterobicyclic compounds and their use for the treatment of tuberculosis.
UY36263A (en) TIAZIN-2-AMINA COMPOUNDS FUSED WITH CYCLOPROPYL AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
CO2017001528A2 (en) Novel substituted pyrimidine compounds
CO2017001506A2 (en) Novel substituted pyrimidine compounds
MX2016003892A (en) Use of substituted dihydro-oxindolyl sulfonamides, or the salts thereof, for increasing the stress tolerance of plants.
BR112015029348A2 (en) bace inhibitors
CO6491037A2 (en) DERIVATIVES OF PIRAZINOOXAZEPINA
CR20140495A (en) 5-AMINO [1,4] THIAZINES AS INHIBITORS OF BACE1
CL2017001467A1 (en) Dihydropyrimidin - 2 - one compounds and their medical uses
BR112016028022A2 (en) sulfonamide compounds and their uses as stat5 inhibitors